symptoms to AIs. 51 With the increase in its use, AI-related arthralgia is emerging as a major source of symptom burden among its users, with a 28% relative increase compared with placebo. 2 Although the understanding of this symptom is extremely limited, in a recent study among 200 ambulatory breast cancer survivors (BCSs) receiving AIs, 47% reported AI-related joint pain and 44% reported AI-related stiffness. 5 Arthralgia not only impairs function 6 but also can lead to treatment discontinuation. 7 As medical science introduces life-prolonging therapies such as AIs, research is needed to identify and test effective strategies to minimize the side effects of AIs so that both the length and quality of survivorship can be enhanced.
threshold. 10 Numerous animal and human studies showed that electroacupuncture (EA) stimulates the release of endogenous opioids in both brain and spinal cord. 11 In addition, the short-term (8 weeks) and long-term (up to 6 months) efficacies of acupuncture for osteoarthritis of knee have recently been established through several high-quality RCTs. [12] [13] [14] These studies demonstrated that acupuncture not only decreases pain and use of pain medications but also improves function and quality of life.
Many previous trials of acupuncture suffered from poor methodological rigor and generated findings that were difficult to interpret. 15 To begin evaluating the effects of acupuncture for AI-related arthralgia, we proposed a pilot study to test the feasibility of conducting a clinical trial of acupuncture for treatment of AI-related arthralgia among BCSs. The specific aims of this study were to (a) demonstrate the feasibility of recruitment and retention to an acupuncture trial; (b) estimate preliminary effect size, variance, safety, and acceptability of the intervention; (c) explore the effects of acupuncture on fatigue, anxiety/ depression, and sleep; and (d) explore the relationship between response expectancy toward acupuncture and clinical response measured as pain reduction.
Methods

Study Patient Population
We recruited eligible patients from the Rowan Breast Cancer Center of the Abramson Cancer Center of the University of Pennsylvania (Philadelphia, PA). Potential participants included women aged 18 or older; postmenopausal defined as cessation of menstrual period more than 1 year, with history of stage I, II, or III breast cancer; currently receiving AIs (anastrozole, letrozole, or exemestane) as per chart documentation; and can understand written English. Participants must have had joint pain attributable to AIs and had worst joint pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week. Key exclusion criteria were metastatic (stage IV) breast cancer, having finished chemotherapy or radiation therapy less than 4 weeks prior to enrollment because chemotherapy and radiation therapy can cause temporary exacerbation of joint symptoms that typically resolve spontaneously, having had active intervention for pain (such as epidural injection, joint injection, acupuncture, etc) in the last 3 months, and history of bleeding disorder because of the safety related to needle puncturing. Informed consent was conducted and obtained from all participants prior to enrollment. University of Pennsylvania Institutional Review Board approved the study protocol.
Study Intervention
Acupuncture was administered by JJM, a licensed physician acupuncturist with 5 years of experience practicing acupuncture in oncology settings. JJM is also a pain and palliative medicine physician. Intervention was delivered twice a week for 2 weeks, then weekly for 6 more weeks for a total maximum of 10 treatments over 8 weeks. Subjects may opt to have fewer treatments if joint pain is perceived to be much improved. This type of treatment intensity and duration is common in other acupuncture clinical studies and actual clinical practices.
We developed a manualized protocol (ie, a protocol that is standardized in a manual but allow the study acupuncturist to modify treatments based on patient clinical characteristics). [16] [17] [18] We chose a manualized protocol over a fixed acupuncture point protocol because (a) it has been shown to be successful in other trials of acupuncture, 13, 16 (b) the location of joint pain in breast cancer patients can be variable, and (c) the baseline constitutional symptoms of each breast cancer patient are different. The manualized protocol is based on the traditional Chinese medicine theory in which joint pain is generally considered as part of the Bi syndrome. 19, 20 The manualized protocol is modified from that described in the text of the Essence of Acupuncture and Moxibustion. 20 In developing the protocol, the principal investigator consulted with the faculty of the Beijing Institute of Acupuncture and Moxibustion at Beijing, China. The acupuncturist chose at least 4 local points around the joint with most pain. Additionally, at least 4 distant points were used to address the constitutional symptoms such as anxiety and fatigue that are commonly seen in conjunction with pain. This protocol allowed acupuncture to be practiced consistent with the way that is typically done in clinical practice and also provided a structure for this research to be replicated in the future. The needles (25 or 40 mm and 0.25 gauge, Seirin, Seirin-America Inc, Weymouth, MA) were inserted until De Qi (sensation of soreness, distention, tingling, etc) was reported by patients. 21 Two pairs of electrodes were connected at the needles adjacent to the painful joint(s) with 2-Hz electrostimulation provided by a TENS unit. The rationale for electrostimulation was based on animal data suggesting a physiological basis, 11, 22 clinical evidence from previous trials, 12, 14 as well as the principal investigator's clinical experience. The needles were left in place for 20 minutes with brief manipulation at the beginning and the end of therapy.
Data Collection and Outcome Measurement
Outcomes self-reported by patients were used to measure intervention effects. Surveys were administrated at baseline and at week 8 by an RA without the presence of the acupuncturist. Clinical information was obtained via chart abstraction.
To quantify joint symptom severity and functional interference, we developed the Brief Joint Symptom Inventory by modifying the Brief Pain Inventory (BPI). The BPI is one of the most widely used instruments to measure pain in cancer patients and has been demonstrated to be a reliable, valid, and responsive measure. 23 The numerical rating scale ranges from 0 to 10, with 10 indicating the greatest severity or interference. Because breast cancer patients may have many sources of pain such as neuropathy and postsurgical pain, we asked the patient to rate pain severity specific to symptoms "in and around joints" to make the measure more specific. We also added 2 items to quantify joint stiffness, with one item asking the severity of stiffness "after first awakening in the morning" and the other "after sitting, lying, or resting later in the day," on the same 0 to 10 scale.
To define patient-perceived clinical importance, we used Patient Global Impression of Change (PGIC). General questions of this type are often used to track the quality and rate of patient response to therapy. 24 "How would you describe your joint pain since the beginning of therapy? I am: very much worse, much worse, a little worse, the same, a little better, much better, very much better."
Because research suggests pain may often be accompanied by other concurrent symptoms such as fatigue, anxiety/depression, and sleep disturbance, we incorporated previously validated measures to evaluate the potential effect of acupuncture on these symptoms.
Brief Fatigue Inventory. This 9-item instrument was designed to assess the construct of fatigue severity in cancer and noncancer populations. 25 The numerical rating scale ranges from 0 to 10, with 10 indicating the greatest severity or interference. The score of the scale was found to be reliable and valid in diverse cancer populations 25, 26 and responded to changes seen in a pilot acupuncture study. 27 Hospital Anxiety and Depression Scale. It is a 14-item scale with 7 items measuring depression and 7 items measuring anxiety. 28 The scale uses varying response items. Factor analysis showed 2 distinct but correlated factors in cancer patients. 29 The score of the scale has been shown to be both reliable and valid in diverse groups of cancer patients 30 and appears to be a clinically useful instrument in cancer patient care. 31 Pittsburgh Sleep Quality Index (PSQI). This global score was used to determine the effect of treatments on sleep. The psychometric properties of the PSQI have been supported widely in a variety of populations, including BCSs. 32 Recently, this scale was used in a small study of acupuncture for nocturnal hot flashes and sleep quality among healthy postmenopausal women, which demonstrated significant correlations between improvements in PSQI and reductions in nocturnal hot flash severity and frequency. 16 Because emerging research suggests the role of response expectancy in predicting outcome of acupuncture, 33 we used a previously validated 4-item Acupuncture Expectancy Scale (AES) 34 to evaluate the change of response expectancy during acupuncture therapy and the relationship between response expectancy and clinical response to acupuncture.
Statistical Analysis and Sample Size Calculation
Data analysis was performed using the SAS software (SAS version 9.1, SAS Institute, Cary, NC) by Dr Xie and Ms Han. Descriptive and graphical methods were used to examine the distribution and normality of data. Normality assumption of the data was checked and found appropriate. The primary comparison between the week 8 and baseline outcomes was compared using paired t test. For the secondary analysis, we performed Pearson correlation test to examine whether the change in pain was also related to fatigue or anxiety. We also used Pearson correlation to examine the relationship between response expectancy and clinical outcome of acupuncture. All statistical tests were 2 sided. We calculated the sample size based on assumption that standard deviation (SD) will be larger or equal to half of the mean. If acupuncture could have caused 40% reduction in pain severity, we would need 10 subjects to detect such difference using a 2-sided significance level of .05 and power of 80%. A loss to follow-up rate of 15% would necessitate enrollment of 12 subjects to fall within the precision noted in the sample size calculation.
Results
Participant Characteristics
Between July 2007 and December 2007, 40 patients were referred because of joint pain. Of this group, 13 did not return screening telephone calls, 9 did not meet eligibility criteria, 2 had already stopped AIs, 1 was receiving acupuncture elsewhere, and 6 had other medical reasons (eg, recent epidural injection, fracture, metastatic disease). Six patients refused enrollment: 2 due to distance and 4 due to schedule conflicts. Twelve patients enrolled. Demographics of the participants are shown in Table 1 .
The mean age of the women enrolled was 59 years, with an SD of 20 years. Ten patients (83%) were non-Hispanic white, 2 (17%) were non-Hispanic black. Seven (59%) were currently employed, 7 (58%) had graduate or professional schooling. Six (50%) reported worst joint pain in knees, 2 (17%) in wrists/hands, and 4 (33%) in ankles/feet. Eight patients completed 10 treatments, 2 completed 9 treatments (both skipped 1 treatment because of very little pain toward the end of the intervention), 1 patient completed 5 treatments because her pain was very minimal after 3 visits, and 1 patient withdrew from the study intervention after 5 treatments due to development of herpes zoster (her acupuncture treatment was focused on knee pain). Her husband had received zoster vaccine 2 weeks prior.
Safety. Despite needle placement in the same arm as breast cancer surgery, no case of infection, development of, or worsening of lymphedema occurred based on patient self-report and clinician exam. Two grade 1 (mild) pain at the needling sites following acupuncture treatment were reported and spontaneously resolved. All patients provided final assessment, and data were analyzed.
Improvement in Joint Symptoms
At baseline, mean joint pain severity rating (SD) was 5.31 (1.49), joint stiffness was 6.88 (2.43), and joint functional interference was 4.74 (2.70) . At the end of intervention, mean joint pain rating was 1.85 (1.54), joint stiffness was 2.42 (1.89), and joint functional interference was 0.81 (0.83). This change represents an approximately 60% reduction in joint pain from baseline. At the end of intervention based on PGIC rating, 11 subjects considered their joint pain very much better, and 1 subject considered joint pain much better compared with baseline.
Changes in other symptoms related to joint pain. Subjects also experienced a significant reduction in fatigue (from 4.38 to 1.93, P = .005) and anxiety (from 7.08 to 4.83, P = .01). Subjects had a nonstatistically significant reduction in depression (from 5.08 to 3.83, P = .20). Global sleep score did not change before and after the intervention (from 6.83 to 6.17, P = .47), see Table 2 . Although not statistically significant, change in joint pain demonstrated a trend toward correlation to change in fatigue (r = .39; P = .20) and change in anxiety (r = .28; P = .38), see Figure 1 .
Relationship between expectancy and pain improvement.
Response expectancy toward acupuncture increased during the course of the therapy from baseline (13.00, 3.85) to the end of intervention (16.50, 2.58), P < .001. Baseline expectancy was not correlated to change in pain (r = .12; P = .72). Increase in response expectancy may be associated with reduction in pain, although statistically not significant in this small study (r = −0.26; P = .45), see Figure 2 .
Discussion
In this study, we demonstrated successful recruitment and retention to an acupuncture intervention for AI-related arthralgia, as well as preliminary efficacy and safety data. Patients reported an approximately 60% reduction in joint pain severity, stiffness, and functional interference. Acupuncture was well tolerated, and despite needling in arms on the side where breast cancer surgery was performed, no infection, development, or worsening of lymphedema was reported. Acupuncture not only appeared to reduce pain but also may have improved anxiety and fatigue. Furthermore, this is the first known study to demonstrate an increase in response expectancy during acupuncture therapy that may be related to clinical response to acupuncture. It is important to acknowledge the limitations of the study. This single-arm clinical trial aimed at establishing feasibility and preliminary effects. The lack of a control group negates the ability to exclude that findings were due to placebo effect, natural progression of disease, or regression to the mean effect. We did not measure longterm follow-up data after the intervention was completed. The acupuncturist is a physician acupuncturist with pain and palliative expertise, which may limit generalizability of the intervention for application by general community acupuncturists. However, this type of early phase acupuncture trial offers an important opportunity to test recruitment and retention strategies, to refine the acupuncture procedure, and to obtain preliminary effect size and variance. Only by accomplishing such a step can we appropriately design and power a randomized controlled study of acupuncture for symptom palliation in an oncology setting. 35 As shown by our study, only 12 out of 40 potential subjects met eligibility requirement and agreed to participate; thus, future RCTs need to have a sufficient population base and decrease patient barriers to enhance the effective conduct of such studies.
The exact mechanism of action for acupuncture for AI-related arthralgia is not fully understood. Animal and human studies have demonstrated an analgesic effect that is mediated in part by endogenous opioid release. 11 It is possible that increased endogenous opioid and other neurotransmitters may attenuate the pain detection threshold in AI users.
Second, neuroimaging techniques including positron emission tomography scan, [36] [37] [38] single-photon emission computed tomography, 39 and functional magnetic resonance imaging [40] [41] [42] [43] have also provided preliminary evidence that acupuncture may modulate the limbic system, 40, 44 which is involved in processing of cognitive and affective aspects of pain in humans. Furthermore, nonspecific effects such as response expectancy may also play an integral part in mediating the central nervous system response to acupuncture. 36, 38 Thus, future study of the effect of acupuncture for AI-related arthralgia using appropriate imaging techniques may establish the potential mechanism of acupuncture for AI-related arthralgia.
Third, data also suggest that acupuncture may affect peripheral tissue where needles are placed. There is some evidence that acupuncture can cause vasodilatation 45, 46 and connective tissue displacement. [47] [48] [49] Chae et al 50 recently found in a rat model with acute paw edema (induced by carrageenan) that acupuncture stimulation significantly reduced IL-6 level, β-nerve growth factor, and tissue inhibitors of metalloproteinase-1.
Based on the above findings, acupuncture may activate a combination of central and peripheral processes that may act synergistically to create persistent clinical changes for chronic symptoms such as AI-related arthralgia. Thus, using acupuncture and clinically relevant outcomes in both animals as well as humans may serve as an important translational model for understanding the etiology of AI-related arthralgia as well as the mechanisms of acupuncture.
We not only found significant improvement in pain but also associated improvement in anxiety and fatigue. These findings suggest that whether the effect of acupuncture is through central nervous system or peripheral modulation, the effects are likely to be systemic, that is, affecting multiple symptoms simultaneously. Given that cancer patients and survivors often experience multiple symptoms, our finding is particularly encouraging, and future RCTs are needed to evaluate the effects of acupuncture on multiple co-occurring symptoms.
A recent large study that found response expectancy was predictive of outcome of acupuncture in multiple painful syndromes. 33 We did not find a statistically significant correlation between response expectancy and pain outcome, but all the patients in this small study had a relatively high level of response expectancy and it stayed high. Second, all trial participants achieved a substantial clinical response; therefore, the lack of variability of response combined with small sample size may limit the power in detecting statistical significance. Nevertheless, we found that response expectancy increased during the acupuncture. This preliminary finding supports the hypothesis that clinical response may reinforce response expectancy. Therefore, the relationship between response expectancy and clinical outcome in acupuncture may be reciprocal and iterative. The appropriate use of a validated AES 34 in future large randomized, controlled clinical trials may help evaluate the mind-body interaction of acupuncture in achieving sustainable outcome for chronic symptom palliation.
In summary, we have conducted a successful feasibility trial of acupuncture to treat AI-related arthralgia. As AI-related arthralgia is a relatively new clinical phenomenon and very few intervention studies have been performed to address this clinical problem, we believe our effort is an important first step in demonstrating the feasibility of rigorous evaluation of acupuncture for this indication. Future RCTs are needed to establish the comparative efficacy of acupuncture to address AI-related arthralgia, a clinical problem affecting hundreds of thousands of BCSs.
